clinical trial · NCT06926842
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Zealand Pharma·phase2·active not recruiting·n = 221
OverweightType 2 DiabetesObesityPetrelintidePlacebo
brief summary
The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.
started
Apr 22, 2025
primary completion
Aug 13, 2026
completion
Aug 13, 2026
last updated
Jan 15, 2026
official title
A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol